Cargando…

Lean Women on Metformin and Oral Contraceptives for Polycystic Ovary Syndrome Demonstrate a Dehydrated Osteosarcopenic Phenotype: A Pilot Study

Scarce data exist on the body composition of lean women with polycystic ovary syndrome (PCOS) on treatment with metformin and oral contraceptives (OCs). Thirty-four lean (body mass index 18.5–24.9 kg/m(2)) women (17 with PCOS on metformin and OCs treatment for six months and 17 controls) aged 18–40...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stefanaki, Charikleia, Bacopoulou, Flora, Kandaraki, Eleni, Boschiero, Dario, Diamandi-Kandarakis, Evanthia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769734/ https://www.ncbi.nlm.nih.gov/pubmed/31480705 http://dx.doi.org/10.3390/nu11092055

Ejemplares similares

Polycystic Ovary Syndrome and NC-CAH: Distinct Characteristics and Common Findings. A Systematic Review
por: Papadakis, Georgios, et al.
Publicado: (2019)

Hepatokine Profile in Adolescents with Polycystic Ovary Syndrome: A Case–Control Study
por: Giannouli, Aikaterini, et al.
Publicado: (2023)

Systematic Review and Meta-Analysis of the Efficacy and Safety of Metformin and GLP-1 Analogues in Children and Adolescents with Diabetes Mellitus Type 2
por: Carydias, Elisabeth, et al.
Publicado: (2022)

The impact of probiotics' administration on glycemic control, body composition, gut microbiome, mitochondria, and other hormonal signals in adolescents with prediabetes – A randomized, controlled trial study protocol
por: Stefanaki, Charikleia, et al.
Publicado: (2018)

Sexual Dimorphism of Heart Rate Variability in Adolescence: A Case-Control Study on Depression, Anxiety, Stress Levels, Body Composition, and Heart Rate Variability in Adolescents with Impaired Fasting Glucose
por: Stefanaki, Charikleia, et al.
Publicado: (2020)

Metformin increases pressure pain threshold in lean women with polycystic ovary syndrome
por: Kiałka, Marta, et al.
Publicado: (2016)

Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome
por: Yang, Young-Mo, et al.
Publicado: (2015)

Osteosarcopenic Obesity: Current Knowledge, Revised Identification Criteria and Treatment Principles
por: Kelly, Owen J., et al.
Publicado: (2019)

Osteosarcopenic Adiposity and Nutritional Status in Older Nursing Home Residents during the COVID-19 Pandemic
por: Cvijetić, Selma, et al.
Publicado: (2023)

Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome
por: Glintborg, Dorte, et al.
Publicado: (2017)

An Update on Contraception in Polycystic Ovary Syndrome
por: Oguz, Seda Hanife, et al.
Publicado: (2021)

Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease
por: Papalou, Olga, et al.
Publicado: (2019)

Comparison of the effects of metformin, flutamide plus oral contraceptives, and simvastatin on the metabolic consequences of polycystic ovary syndrome
por: Mehrabian, Ferdous, et al.
Publicado: (2016)

PMON208 METFORMIN, SPIRONOLACTONE AND ORAL CONTRACEPTIVES IN POLYCYSTIC OVARY SYNDROME: A NETWORK META-ANALYSIS
por: Rodriguez-Gutierrez, Rene, et al.
Publicado: (2022)

Chronic Stress Contributes to Osteosarcopenic Adiposity via Inflammation and Immune Modulation: The Case for More Precise Nutritional Investigation
por: Ilich, Jasminka Z., et al.
Publicado: (2020)

Vitamin D in Osteosarcopenic Obesity
por: Di Filippo, Luigi, et al.
Publicado: (2022)

Probiotics in Adolescent Prediabetes: A Pilot RCT on Glycemic Control and Intestinal Bacteriome
por: Stefanaki, Charikleia, et al.
Publicado: (2019)

Hypertension Predisposition and Thermoregulation Delays in Adolescents with Polycystic Ovary Syndrome: A Pilot Study
por: Geronikolou, Styliani, et al.
Publicado: (2022)

Osteosarcopenic Visceral Obesity and Osteosarcopenic Subcutaneous Obesity, Two New Phenotypes of Sarcopenia: Prevalence, Metabolic Profile, and Risk Factors
por: Perna, Simone, et al.
Publicado: (2018)

Physical Properties of Blood Are Altered in Young and Lean Women with Polycystic Ovary Syndrome
por: Simmonds, Michael J., et al.
Publicado: (2016)

Evaluation of Mean Platelet Volume values in lean women with polycystic ovary syndrome
por: Silfeler, Dilek Benk, et al.
Publicado: (2014)

Debates Regarding Lean Patients with Polycystic Ovary Syndrome: A Narrative Review
por: Goyal, Manu, et al.
Publicado: (2017)

Effects of metformin use in pregnant patients with polycystic ovary syndrome
por: Kumar, Pratap, et al.
Publicado: (2012)

Role of Metformin in Polycystic Ovary Syndrome (PCOS)-Related Infertility
por: Attia, Ghalia M, et al.
Publicado: (2023)

Metformin and tBHQ Treatment Combined with an Exercise Regime Prevents Osteosarcopenic Obesity in Middle-Aged Wistar Female Rats
por: Toledo-Pérez, Rafael, et al.
Publicado: (2021)

Contraception for Women with Polycystic Ovary Syndrome: Dealing with a Complex Condition
por: Spritzer, Poli Mara
Publicado: (2022)

The effects of obesity and polycystic ovary syndrome on serum lipocalin-2 levels: a cross-sectional study
por: Panidis, Dimitrios, et al.
Publicado: (2010)

Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis
por: Zeng, Huamin, et al.
Publicado: (2023)

Osteosarcopenic obesity: the role of bone, muscle, and fat on health
por: Ormsbee, Michael J., et al.
Publicado: (2014)

Osteosarcopenic obesity in women: impact, prevalence, and management challenges
por: JafariNasabian, Pegah, et al.
Publicado: (2017)

The monocyte counts to HDL cholesterol ratio in obese and lean patients with polycystic ovary syndrome
por: Usta, Akin, et al.
Publicado: (2018)

Effect of Metformin on Serum Ferritin Level in Women with Polycystic Ovary Syndrome
por: Behradmanesh, S, et al.
Publicado: (2011)

Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome
por: Shahebrahimi, Karoon, et al.
Publicado: (2016)

Clinical outcome of various metformin treatments for women with polycystic ovary syndrome
por: Matsuzaki, Toshiya, et al.
Publicado: (2017)

Metformin improves polycystic ovary syndrome in mice by inhibiting ovarian ferroptosis
por: Peng, Qingjie, et al.
Publicado: (2023)

Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome
por: Krysiak, Robert, et al.
Publicado: (2023)

The Burden of Non-Alcoholic Fatty Liver Disease in Adolescents with Polycystic Ovary Syndrome: A Case–Control Study
por: Giannouli, Aikaterini, et al.
Publicado: (2023)

Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits
por: de Melo, Anderson Sanches, et al.
Publicado: (2017)

Polycystic Ovary Syndrome and Psychotic Disorder
por: Doretto, Larissa, et al.
Publicado: (2020)

Circulating Levels of Vitamin D(3) and Leptin in Lean Infertile Women with Polycystic Ovary Syndrome
por: Dawood, Ayman Shehata, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_17b80kss8dmsq1r312f7lshsm4